Abstract
Acyclic nucleoside phosphonates (ANPs) inhibit replication of both DNA viruses and retroviruses, including HIV. The major mechanism of their antiviral action is inhibition of virus-induced DNA polymerases and/or of reverse transcriptases. We investigated the effects of ANPs on proliferation of mitogen-stimulated mouse and rat splenocytes. Included in the study were compounds differing at the heterocyclic base, i.e., adenine (A) and 2,6-diaminopurine (DAP), and at the N 9-side chain, i.e., 9-[2-(phosphonomethoxy)ethyl] (PME) and ( R)- or ( S)-enantiomers of 9-[2-(phosphonomethoxy)propyl] (PMP) moieties, and their numerous N 6-substituted derivatives. The medial inhibitory concentrations (IC50) of N 6-nonsubstituted compounds range from 0.13 (PMEDAP) to 354 μM (( R)-PMPA). Antiproliferative effects are more pronounced in PME than in PMP series, and they are more prominent in DAP compared to A analogs. The ( S)-enantiomers of PMP series are more effective than corresponding ( R)-congers. The highest cytostatic potential is exhibited by N 6-allyl-PMEDAP (IC50 = 0.017 μM) and N 6-cyclopropyl-PMEDAP (IC50 = 0.036 μM). The N 6-substituted derivatives of ( S)-PMPA are virtually devoid of cytostatic activity. No tight correlation between the cytostatic and reported antiviral effects could be detected.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.